RNAZ · Transcode Therapeutics, Inc. · Documents
$1.70
+0.00 (+0.00%)
At close · Oct 19
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“Due to the Company's recurring and expected continuing losses from operations, the Company has concluded there is substantial doubt concerning its ability to continue as a going concern for one year after the issuance of these consolidated financial statements without additional capital becoming available.”View the 10-Q filed Aug 14, 2026
Market Cap
$28.78M
Shares
16.93M
Volume · Oct 19
29.32K
Avg daily vol (3M)
53.32K
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | AI summary | Filing Date | Period | Open |
|---|---|---|---|---|
| 8-K | — | 2025-06-13 | 2025-06-12 | |
| 10-Q | — | 2025-05-14 | 2025-03-31 | |
| 8-K | — | 2025-05-07 | 2025-05-06 | |
| 8-K | — | 2025-05-05 | — | |
| 8-K | — | 2025-05-02 | — | |
| 10-K/A | — | 2025-04-30 | 2024-12-31 | |
| 8-K | — | 2025-04-21 | — | |
| DEFA14A | — | 2025-04-21 | — | |
| DEFA14A | — | 2025-04-16 | — | |
| 10-K | — | 2025-04-15 | 2024-12-31 | |
| DEF 14A | — | 2025-04-11 | 2025-04-21 | |
| PRE 14A | — | 2025-04-02 | — | |
| NT 10-K | — | 2025-03-31 | 2024-12-31 | |
| 8-K | — | 2025-03-25 | 2025-03-23 | |
| 8-K | — | 2025-02-25 | — | |
| 8-K | — | 2025-02-04 | — | |
| DEFA14A | — | 2025-02-04 | — | |
| DEF 14A | — | 2024-12-30 | 2025-02-04 | |
| 8-K | — | 2024-12-20 | 2024-12-18 | |
| PRE 14A | — | 2024-12-19 | 2025-02-28 | |
| S-1 | — | 2024-12-06 | — | |
| 8-K | — | 2024-12-02 | 2024-11-26 | |
| 8-K | — | 2024-11-29 | 2024-11-26 | |
| 8-K | — | 2024-11-25 | 2024-11-22 | |
| 10-Q | — | 2024-11-14 | 2024-09-30 | |
| DEFA14A | — | 2024-11-13 | — | |
| 8-K | — | 2024-11-06 | 2024-11-04 | |
| DEFA14A | — | 2024-11-06 | — | |
| DEF 14A | — | 2024-10-28 | 2024-11-22 | |
| PRE 14A | — | 2024-10-15 | — | |
| 8-K | — | 2024-09-27 | 2024-09-23 | |
| 8-K | — | 2024-08-28 | — | |
| 8-K | — | 2024-08-16 | 2024-08-13 | |
| 10-Q | — | 2024-08-14 | 2024-06-30 | |
| 8-K | — | 2024-07-24 | 2024-07-22 | |
| 8-K/A | — | 2024-06-14 | 2024-06-13 | |
| 8-K | — | 2024-06-13 | — | |
| DEFA14A | — | 2024-06-10 | — | |
| 8-K | — | 2024-06-07 | 2024-06-03 | |
| DEFA14A | — | 2024-06-07 | — | |
| DEFR14A | — | 2024-05-20 | — | |
| 8-K | — | 2024-05-15 | — | |
| 10-Q | — | 2024-05-15 | 2024-03-31 | |
| DEFA14A | — | 2024-05-13 | — | |
| 8-K | — | 2024-05-10 | 2024-05-07 | |
| PRE 14A | — | 2024-05-10 | 2024-06-13 | |
| ARS | — | 2024-04-29 | 2023-12-31 | |
| DEF 14A | — | 2024-04-29 | 2024-06-13 | |
| 8-K | — | 2024-04-23 | 2024-04-22 | |
| 8-K | — | 2024-04-05 | 2024-04-03 |
Showing 51–100 of 174 filings